Skip to content

Clinical trials

Phase 3 Hepatitis C, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 3 Clear all

182 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20029
20035
20048
200511
20069
20076
20088
20096
20104
201118
201225
201314
201413
201517
201610
20179
20182
20191
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed145
Terminated17
Unknown status10
Withdrawn9
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie34
Merck Sharp & Dohme LLC31
Gilead Sciences11
Hoffmann-La Roche7
Tanabe Pharma Corporation7
Boehringer Ingelheim6
French National Agency for Research on AIDS and Viral Hepatitis6
AbbVie (prior sponsor, Abbott)5
Bausch Health Americas, Inc.4
Janssen Pharmaceutical K.K.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic182
Hepatitis C82
Fibrosis17
Hepatitis10
Liver Cirrhosis9
Liver Diseases8
Infections6
Virus Diseases6
Acquired Immunodeficiency Syndrome5
Hepatitis, Chronic5

Trials

Showing 1 to 25 of 182. Each trial links to its page on Pharma Observatory.

82 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.